Media Blame Donald Trump for Man’s Death After Ingesting

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone energy_wave #43097
173
Media Blame Donald Trump for Man’s Death After Ingesting Fish Tank Cleaner
< >

Trump-koi-Getty-640x480.jpg

The media rushed to blame President Donald Trump on Monday for the death of an Arizona man who ingested a form of chloroquine — before it turned out that the man had ingested a fish tank cleaner with a similar chemical.

Reuters reported:

An Arizona man has died and his wife is in critical condition after they ingested chloroquine phosphate – an aquarium cleaning product similar to drugs that have been named by President Trump as potential treatments for coronavirus infection.

The couple, in their 60s, experienced immediate distress after swallowing the drug, an additive used at aquariums to clean fish tanks, according to Banner Health Hospital in Phoenix.

Chloroquine phosphate shares the same active ingredient as malaria drugs that President Trump has touted as possibly effective against COVID-19, the potentially life-threatening disease caused by the coronavirus.

Many media outlets, however, reported that the man died after taking “chloroquine.”

Axios, for example, had to delete a tweet and issue a correction after reporting, initially: “Man dies after self-medicating with chloroquine.”

We have deleted this tweet and corrected our story because it did not reflect the full nature of the self-medication done with an additive commonly used to clean fish tanks. https://t.co/0zucqRaIkI pic.twitter.com/3YY86rju2w

— Axios (@axios) March 24, 2020

The website added an “editor’s note” to the story: “Editor’s note: This story has been updated to reflect the fact that the form of chloroquine the couple ingested was used in aquariums — and it was not a medication.”

BuzzFeed reported: “A Man Died After Self-Medicating With A Drug Trump Promoted As A Potential Treatment For The Coronavirus.”

The text described “a drug meant for aquariums” without distinguishing between a product sold for fish tanks and a product for humans prepared by a pharmacist and supplied with a medical prescription.

President Trump has spoken specifically about the medically-supervised use of chloroquine — specifically, a drug called hydroxychloroquine, often used in combination with azithromycin, which has shown anecdotal efficacy in treating coronavirus victims, though it has not yet been proven to do so in clinical trials.

On Monday, he praised New York Governor Andrew Cuomo for launching clinical trials of the experimental medication regimen. Trump spoke specifically about “the hydroxychloroquine and the Z-Pak,” the latter another name for azithromycin.

Last week, NBC News’ Peter Alexander accused Trump of giving Americans “false hope” by touting the potential of the drug. The false claims about Trump encouraging a man to ingest fish tank cleaner are in the same vein.

After Trump supporters noticed the errors in reporting about the man’s death, the phrase “FISH TANK CLEANER” began trending nationwide on Twitter late Monday night.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 84

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Patriot Fund Gala Celebrates Veterans and America's 250th

Updated Category News Views 44

Celebrating Service and Patriotism in Philadelphia The Patriot Fund is gearing up for its 11th Annual Gala, a night dedicated to honoring the veterans who have sacrificed so much for this nation. Set against the historic backdrop of Philadelphia, the gala coincides with America's 250th anniversary—couldn't have picked a better time or place for such an event. It’s not...

Continue Reading
Netcapital's Revenue Fraud Scandal Hits Investor Confidence

Updated Category News Views 60

The Rise and Fall of Netcapital: A Troubling Drop Netcapital Inc. (NASDAQ: NCPL) has found itself in hot water with investors after revelations of a wild scheme to fluff up its revenue figures. It’s like watching a house of cards crumble — and investors are left holding the bag. From December 15, 2021, through September 3, 2026, a slew of misinformation allegedly...

Continue Reading
Leviton Ignites Bridgestone Arena's Modern Makeover

Updated Category News Views 36

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 0

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Medline's MedTrans Rodeo: Honoring Driver Excellence

Updated Category News Views 72

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
CASEKOO's Spooky Collectibles: Postcards Meet Cases

Updated Category News Views 49

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

Continue Reading
Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Updated Category News Views 6

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

MacroGenics, Inc. Investors Urged for Legal Deadlines Awareness

Updated Category News Views 83

Attention MacroGenics Investors MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company dedicated to creating and selling innovative treatments, is currently facing an ongoing securities class action lawsuit. If you own or have owned shares of MacroGenics within a certain timeframe, it's important to be aware of this situation, as it may significantly affect your...

Continue Reading
Analyzing Micron Technology's Stock Performance Amid Challenges

Updated Category News Views 143

Micron Technology's Recent Stock Struggles In recent weeks, Micron Technology Inc. has encountered significant hurdles, causing its stock price to fall sharply. The manufacturer of computer memory chips continues to experience an extended selloff, heavily influenced by analysts expressing concerns about its standing in the artificial intelligence market. Impact of Analyst...

Continue Reading
Peter Schiff Critiques Government Spending on Cryptocurrency

Updated Category News Views 86

Peter Schiff's Critique on Government Cryptocurrency Investments Bitcoin critic Peter Schiff has recently expressed strong opinions against the government's foray into cryptocurrency, labeling these investments as a significant misallocation of public resources. Schiff's viewpoint is clear: countries that actively engage in holding digital assets are likely to end up as...

Continue Reading
Concerns Grow Among British Businesses Over New Regulations

Updated Category News Views 158

Concerns from British Businesses About Employment Regulations Many British businesses are voicing serious concerns about the new employment regulations proposed by the recently elected Labour government. Their anxiety primarily arises from the fear that enhanced protections for employees might complicate the hiring process, as emphasized by the Confederation of British...

Continue Reading
Faruqi & Faruqi Investigates Investors' Claims on STZ

Updated Category News Views 176

Faruqi & Faruqi Investigates Claims for Investors Faruqi & Faruqi, LLP is a prominent national securities law firm that is currently examining possible claims related to Constellation Brands, Inc. (NYSE: STZ). The firm invites investors who may have experienced losses exceeding $50,000 in Constellation Brands to reach out for professional guidance and support. Legal...

Continue Reading